Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Vaccines

Free Subscription 19.01.2026 2 BMJ 1 J Gen Virol 1 J Infect 3 JAMA 5 Lancet 2 N Engl J Med 1 Nat Med 1 PLoS Med 2 PLoS One 1 Science 24 Vaccine 1 Virology 2 Virus Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMJ

1. BARANIUK C
   mRNA vaccines are under threat-could cancer vaccines be the answer?
   BMJ. 2026;392:r2449.
   PubMed        
   
   
2. WISE J
   Covid vaccine hesitancy decreased over time, but mistrust persists in some groups, study suggests.
   BMJ. 2026;392:s67.
   PubMed        
   
   

   
   J Gen Virol

3. MIMMS JL, Sinnis-Bourozikas A, Felbinger NR, Frumento N, et al
   Antigenicity of key hepatitis C virus E1E2 glycoprotein neutralizing sites is genotype independent.
   J Gen Virol. 2026;107:002201.
   PubMed         Abstract available
   
   

   
   J Infect

4. GEERS D, Aguilar-Bretones M, Zaeck LM, Gill PA, et al
   Preferential boosting of SARS-CoV-2 Omicron lineage-specific immune responses by monovalent XBB.1.5 vaccination.
   J Infect. 2026;92:106681.
   PubMed         Abstract available
   
   

   
   JAMA

5. RUBIN R
   Nudging Increases Flu Vaccine Uptake.
   JAMA. 2026 Jan 16. doi: 10.1001/jama.2025.23023.
   PubMed        
   
   
6. FATTAH M, Stoffel LA, Bubar KM, Bents SJ, et al
   Trends in County-Level Childhood Vaccination Exemptions in the US.
   JAMA. 2026 Jan 14:e2524407. doi: 10.1001/jama.2025.24407.
   PubMed        
   
   
7. MELLO MM, Walensky RP, Osterholm MT, Brennan TA, et al
   Navigating Conflicting Vaccination Recommendations: Guidance for Clinicians.
   JAMA. 2026 Jan 13. doi: 10.1001/jama.2026.0276.
   PubMed        
   
   

   
   Lancet

8. VAN GEERTRUYDEN JP, Lariviere Y, Zola Matuvanga T, Van Damme P, et al
   Ebola and health-care providers: the case for preventive vaccination.
   Lancet. 2026 Jan 12:S0140-6736(25)02459-6. doi: 10.1016/S0140-6736(25)02459.
   PubMed        
   
   
9. WHITAKER M, Elliott J, Gerard-Ursin I, Cooke GS, et al
   Profiling vaccine attitudes and subsequent uptake in 1.1 million people in England: a nationwide cohort study.
   Lancet. 2026 Jan 12:S0140-6736(25)01912-9. doi: 10.1016/S0140-6736(25)01912.
   PubMed         Abstract available
   
   
10. PALMIERI C, Tafuri S
    Vaccine hesitancy: an evolving challenge.
    Lancet. 2026 Jan 12:S0140-6736(25)02601-7. doi: 10.1016/S0140-6736(25)02601.
    PubMed        
    
    
11. TURTLE L
    Yellow fever vaccine minimum fractional dosing does not extend to infants.
    Lancet. 2026 Jan 13:S0140-6736(25)02364-5. doi: 10.1016/S0140-6736(25)02364.
    PubMed        
    
    
12. KIMATHI D, Juan-Giner A, Bob NS, Orindi B, et al
    Low-dose yellow fever vaccination in infants: a randomised, double-blind, non-inferiority trial.
    Lancet. 2026 Jan 13:S0140-6736(25)02069-0. doi: 10.1016/S0140-6736(25)02069.
    PubMed         Abstract available
    
    

    
    N Engl J Med

13. CAI M, Xie Y, Al-Aly Z
    2024-2025 Covid-19 Vaccine Outcomes in U.S. Veterans. Reply.
    N Engl J Med. 2026;394:307.
    PubMed        
    
    
14. YANG C, Tebbutt SJ
    2024-2025 Covid-19 Vaccine Outcomes in U.S. Veterans.
    N Engl J Med. 2026;394:306-307.
    PubMed        
    
    

    
    Nat Med

15. D'ALISE AM, Willis J, Duzagac F, Hall MJ, et al
    Nous-209 neoantigen vaccine for cancer prevention in Lynch syndrome carriers: a phase 1b/2 trial.
    Nat Med. 2026 Jan 16. doi: 10.1038/s41591-025-04182.
    PubMed         Abstract available
    
    

    
    PLoS Med

16. STANTON TD, Keegan SP, Abdulahi JA, Amulele AV, et al
    Distribution of capsule and O types in Klebsiella pneumoniae causing neonatal sepsis in Africa and South Asia: A meta-analysis of genome-predicted serotype prevalence to inform potential vaccine coverage.
    PLoS Med. 2026;23:e1004879.
    PubMed         Abstract available
    
    

    
    PLoS One

17. CUI L, Tong N, Hou S, Yu C, et al
    Adverse events following Synflorix vaccination reported to the Vaccine Adverse Event Reporting System (VAERS), 2010-2024.
    PLoS One. 2026;21:e0338640.
    PubMed         Abstract available
    
    
18. ZENG Z, Sathasivam S, Xin J, Zhao H, et al
    Public participation in healthcare safety: A tripartite evolutionary game model with evidence from diverse international cases.
    PLoS One. 2026;21:e0339304.
    PubMed         Abstract available
    
    

    
    Science

19. COHEN J
    Scientists reject call to retest childhood vaccines.
    Science. 2026;391:220-221.
    PubMed         Abstract available
    
    

    
    Vaccine

20. MALLET A, Jaunay LB, Jaury P, Partouche H, et al
    Vaccine refusal during the COVID-19 pandemic: A qualitative study.
    Vaccine. 2026;74:128206.
    PubMed         Abstract available
    
    
21. HEBERT LS, Pickens W, Satterwhite E, Soto GB, et al
    Erratum to "Gene discovery and expression analysis of the B cell receptor repertoire in the domestic ferret model" [Vaccine 64 (2025) 127725].
    Vaccine. 2026;74:128161.
    PubMed        
    
    
22. FAY MJ, Howe AS, Wilson E, Sinclair O, et al
    Impact of a single-dose program on varicella hospitalizations and infectious disease inequity in New Zealand: A retrospective cohort study.
    Vaccine. 2026;72:128082.
    PubMed         Abstract available
    
    
23. CATA-PRETA BO, Arroyave L, Costa FS, Mengistu T, et al
    Monitoring the SDG immunization indicator: Approaches and challenges.
    Vaccine. 2026;72:128118.
    PubMed         Abstract available
    
    
24. DRISLANE S, Moore H, Attwell K
    Understanding parental decisions to decline or delay infant RSV immunisation, nirsevimab, in Western Australia in 2024.
    Vaccine. 2026;72:128133.
    PubMed         Abstract available
    
    
25. SINCLAIR JE, Mayfield HJ, Lu H, Brown SJ, et al
    Estimating risk of long COVID using a Bayesian network-based decision support tool.
    Vaccine. 2026;72:128127.
    PubMed         Abstract available
    
    
26. JABBAR F, Kadhim KA, Alhilfi RA, Al Khafaji IS, et al
    Advancements in monitoring adverse events following immunization in Iraq: Insights from the CIVIE project 2022-2023.
    Vaccine. 2026;72:128121.
    PubMed         Abstract available
    
    
27. ZINTGRAFF J, Gagetti P, Eluchans NS, Marchetti P, et al
    Serotype distribution and antimicrobial resistance in pediatric invasive pneumococcal pneumonia: A Laboratory Surveillance Study from Argentina, 2022-2024.
    Vaccine. 2026;72:128128.
    PubMed         Abstract available
    
    
28. TIPTON T, Laidlaw S, Nguyen D, Longet S, et al
    ACE2 inhibition ELISA is an effective surrogate for SARS-CoV-2 live virus neutralisation.
    Vaccine. 2026;72:128123.
    PubMed         Abstract available
    
    
29. DE OLIVEIRA NR, Maia MAC, Bunde TT, Pedra ACK, et al
    A self-assembled Pirococcus abyssi exosome complex displaying outer membrane proteins of Leptospira interrogans elicits protective immunity against leptospirosis.
    Vaccine. 2026;73:128159.
    PubMed         Abstract available
    
    
30. DAS S, Begum F, Ghora S, Ray U, et al
    Engineered dengue virus NS1 mRNA-lipid nanoparticle induces therapeutic IgG production that lacks autoantibody activity and neutralizes NS1 entry in liver cells.
    Vaccine. 2026;73:128147.
    PubMed         Abstract available
    
    
31. TYAGI P, Ganguly M, Manney S, Wadkar K, et al
    Plaque reduction neutralization test (PRNT(50)) for the detection of anti-yellow fever antibodies from clinical samples.
    Vaccine. 2026;73:128151.
    PubMed         Abstract available
    
    
32. SETHNA V, Apte A, Sanghavi S, Tang Y, et al
    Nasopharyngeal pneumococcal carriage in Indian children following 10-valent PCV (PNEUMOSIL(R)) introduction through India's universal immunization program: A post licensure cross-sectional study.
    Vaccine. 2026;73:128129.
    PubMed         Abstract available
    
    
33. HARKER EJ, Lewis NM, Johnson CA, Zhu Y, et al
    Differences in influenza vaccine effectiveness by sex among adults hospitalized with acute respiratory illness-IVY network, January 24, 2022-September 1, 2024.
    Vaccine. 2026;74:128192.
    PubMed         Abstract available
    
    
34. SABIR R, Liu M, Saeed HA, Deng Z, et al
    Next-generation live vector vaccine targeting Mycoplasma synoviae and Mycoplasma gallisepticum via recombinant Salmonella.
    Vaccine. 2026;74:128211.
    PubMed         Abstract available
    
    
35. SHENG S, Sun Y, Qin J, Zhao J, et al
    Hepatitis B core antigen-based trivalent VLP vaccine against porcine viral diarrhea.
    Vaccine. 2026;74:128210.
    PubMed         Abstract available
    
    
36. PAGE CL, Holbrook BC, Miller LD, Grayson JM, et al
    TLR5 versus TLR7/8 agonist-dependent modulation of the early gene expression response to inactivated influenza virus vaccine in newborn nonhuman primates.
    Vaccine. 2026;74:128163.
    PubMed         Abstract available
    
    
37. DE MORAES JC, Ribeiro KB, Vargas-Zambrano JC, Rujula MJP, et al
    Parental perceptions of adverse events associated with the whole-cell pertussis vaccine in Brazil.
    Vaccine. 2026;74:128184.
    PubMed         Abstract available
    
    
38. COBLENTZ EG, Packee CR, Ky SL, Brubaker AG, et al
    Prioritization of HPV vaccine preventable diseases among emerging adults - Implications for health education and communication.
    Vaccine. 2026;74:128223.
    PubMed         Abstract available
    
    
39. LU Y, Zhao W, Xu S, Tang C, et al
    Effectiveness of information interventions in reducing HPV vaccine hesitancy: a randomized survey experiment in China.
    Vaccine. 2026;74:128205.
    PubMed         Abstract available
    
    
40. CHENG K, Pullenayegum E, Singh P, Loeb M, et al
    Use of composite outcomes in cluster randomized control trials of influenza vaccines.
    Vaccine. 2026;74:128224.
    PubMed         Abstract available
    
    
41. VEERARAGHAVAN B, Varghese R, Gurumoorthy M
    Beyond serotypes: Why GPSC10 redefines vaccine escape in the pneumococcal vaccine era.
    Vaccine. 2026;74:128238.
    PubMed        
    
    
42. PATERNINA-DE LA OSSA R, Oliveira MC, Achcar JA, Zanin-Silva DC, et al
    Immunological responses to tetanus, diphtheria, pertussis (Tdap) vaccine in Brazilian hematopoietic stem cell transplant recipients.
    Vaccine. 2026;75:128250.
    PubMed         Abstract available
    
    
43. DE WALS P, Papenburg J, Gilca R, Brousseau N, et al
    Are hemagglutinin-only influenza vaccines as effective as conventional influenza vaccines against severe infection?
    Vaccine. 2026;74:128234.
    PubMed        
    
    

    
    Virology

44. THOMAS MH, Carlock MA, Ross TM
    Adjuvants enhance protective antibodies against seasonal influenza viruses following a single vaccination of Fluzone.
    Virology. 2026;616:110787.
    PubMed         Abstract available
    
    

    
    Virus Res

45. NAZKI S, Reine J, Kailath R, Gilbert S, et al
    Replication-incompetent viral vaccine vectors ChAdOx1 and MVA as tools for evaluating T-cell responses to naturally processed antigens in vitro.
    Virus Res. 2026;364:199691.
    PubMed         Abstract available
    
    
46. NGUYEN TTN, Tun MMN, Vu TBH, Nguyen TTT, et al
    Implications of Immune Responses to DENV, JEV, and ZIKV Infections for Cross-Reactivity and Considerations for Vaccine Evaluation.
    Virus Res. 2026 Jan 8:199689. doi: 10.1016/j.virusres.2026.199689.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.